课题基金 / 基金详情

Structural analysis of protective and non-protective T-cell epitopes encoded with in the retroviral gag gene product

Structural analysis of protective and non-protective T-cell epitopes encoded with in the retroviral gag gene product
逆转录病毒 gag 基因产物编码的保护性和非保护性 T 细胞表位的结构分析
批准号:
13670305
负责人:
MIYAZAWA Masaaki
金额:
$0.51万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

MIYAZAWA Masaaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1) One of the mouse retroviral gag gene products, the N-terminal MA protein, contains multiple T-lymphocyte epitopes recognized by CD4-positive helper cells. One of these T-helper cell epitopes was mapped within amino acid residues 62 and 76, and another epitope was localized between residues 119 and 138 in the MA protein.2) CD4-positive T cells specifically reacting to the 62-76 epitope produced a large amount of IL-4, while T cells reactive to the epitope within 119-138 did not.3) To identify the antigenic structures that are required for protection against retroviral infection, various truncated forms of MA were expressed in a newly modified vaccinia virus vector, and mice were immunized with the resultant recombinant vaccinia viruses. All the truncated forms of MA lost the ability to protect mice, while the entire MA was effective. To elucidate if the truncation in the N-terminal portion affected the effectiveness of the whole MA due to the lack of the N-terminal residue required for protein myristylation, Gly at residue 2 was replaced with Ala in a mutant MA. This mutant MA localized in the cell nuclei, instead of cell membrane where myristylated proteins normally accumulate, and at the same time the vaccinia virus expressing this mutant MA lost its ability to protect mice against retroviral infection.4) Thus, myristylation of MA is necessary for its proper immunogenicity, and when myristylated, the Th2 epitope is not necessary, but an epitope in the C-terminal portion is required for protective efficacy of MA.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Sugita, J.: "Close association of Fas ligand-positive tumor-associated macrophages and apoptotic cancer cells along invasive margins of colorectal carcinoma interactions"Jpn.J.Cancer Res.. 93. 320-328 (2002)
Sugita, J.:“Fas 配体阳性肿瘤相关巨噬细胞和凋亡癌细胞沿着结直肠癌相互作用的侵袭边缘的紧密关联”Jpn.J.Cancer Res.. 93. 320-328 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sugita, J.: "Close association between Fas ligand-positive tumor-associated macrophages and apoptotic cancer cells invasive margins of colorectal carcinoma"Jpn. J. Cancer Res.. 93. 320-328 (2002)
Sugita, J.:“Fas 配体阳性肿瘤相关巨噬细胞与凋亡癌细胞侵袭结直肠癌边缘之间的密切关联”Jpn。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
山岸秀夫, 宮澤正顕: "からだを守る"昭和堂(京都市). 168 (2001)
山岸秀雄、宫泽正明:“保护你的身体”昭和 (京都市) 168 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
18
    Designing novel protease inhibitors based on the interference of mouse APOBEC3 with retroviral Gag-Pol autocatalysis
    • 批准号:
      16H05199
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.24万
    • 财政年份:
      2016
    • 负责人:
      MIYAZAWA Masaaki
    • 依托单位:
    Mechanisms of regulation of host immune responses by retrovirus-restricting enzyme APOBEC3
    • 批准号:
      24390116
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2012
    • 负责人:
      MIYAZAWA Masaaki
    • 依托单位:
    Regulation of APOBEC3 gene expression and its transcript splicing
    • 批准号:
      21390143
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.15万
    • 财政年份:
      2009
    • 负责人:
      MIYAZAWA Masaaki
    • 依托单位:
    Analyses of host genes that confer immune resistance against human immunodeficiency virus type-1 infection in HIV-1-exposed but uninfected individuals in the overseas cohorts
    • 批准号:
      15406021
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.8万
    • 财政年份:
      2003
    • 负责人:
      MIYAZAWA Masaaki
    • 依托单位:
    国内基金
    海外基金
    SENP5调控磷酸化STAT2的SUMO修饰促进抗病毒天然免疫的机制研 究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      胡源
    • 依托单位:
    外周犬尿氨酸通过脑膜免疫致海马BDNF水平降低介导术后认知功能障碍
    • 批准号:
      82371193
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      苏殿三
    • 依托单位:
    microRNA对机体抗病毒固有免疫应答RIG-I信号途径的调控作用及机制研究
    C型凝集素样受体识别在原发性皮肤毛霉病中的作用
    • 批准号:
      81171510
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2011
    • 负责人:
      李若瑜
    • 依托单位: